FPN || News

High rate of durable responses to pembrolizumab in metastatic melanoma

Posted on: 03/06/2014 - 19:35

CHICAGO – The investigational targeted agent pembrolizumab induced durable treatment responses in a high percentage of patients with advanced metastatic melanoma, in a phase I study. Of 411...

Field of Interest: Oncology

Type: News Item

Tests may help before liver transplant, not after

Posted on: 03/06/2014 - 15:15

CHICAGO – Two laboratory measurements that are commonly used to assess the cause of symptomatic ascites before liver transplant may be deceptive when used to assess posttransplant ascites, a...

Field of Interest: Gastroentero...

Type: News Item

VIDEO: New option arises for young women with hormone-sensitive breast cancer

Posted on: 02/06/2014 - 22:40

CHICAGO – The aromatase inhibitor exemestane is more effective than tamoxifen in preventing breast cancer recurrence in premenopausal women also receiving ovarian function suppression as adjuvant...

Field of Interest: Oncology

Type: News Item

VIDEO: New option arises for young women with hormone-sensitive breast cancer

Posted on: 02/06/2014 - 22:40

Field of Interest: Pulmonology

Type: News Item

LEEP procedures present an important STI screening opportunity

Posted on: 02/06/2014 - 22:20

CHICAGO – Many women who undergo a loop electrosurgical excision procedure for advanced cervical dysplasia are not screened for HIV and other sexually transmitted diseases, according to findings from...

Field of Interest: Pulmonology

Type: News Item

VIDEO: Adding docetaxel up front improved survival in prostate cancer by more than a year

Posted on: 02/06/2014 - 20:50

CHICAGO –The answer was nearly a decade in coming, but worth the wait: Adding docetaxel to initial hormonal therapy in men with metastatic, hormone-sensitive prostate cancer can extend overall...

Field of Interest: Oncology

Type: News Item

Drug combo extends survival by more than 1 year in metastatic prostate cancer patients

Posted on: 02/06/2014 - 18:55

CHICAGO – The answer was nearly a decade in coming, but worth the wait: Adding docetaxel to initial hormonal therapy in men with metastatic, hormone-sensitive prostate cancer can extend overall...

Field of Interest: Oncology

Type: News Item

Goserelin improves fertility in HR-negative breast cancer

Posted on: 02/06/2014 - 15:45

CHICAGO – Use of the gonadotropin-releasing hormone agonist goserelin during chemotherapy for early hormone receptor–negative breast cancer was associated with lower rates of ovarian failure and more...

Field of Interest: Pulmonology

Type: News Item

Goserelin improves fertility in HR-negative breast cancer

Posted on: 02/06/2014 - 15:45

Field of Interest: Oncology

Type: News Item

Diet modifications highly effective in EoE

Posted on: 01/06/2014 - 05:01

An elemental diet was more than 90% effective in inducing histologic remission in eosinophilic esophagitis patients, reported Dr. Ángel Arias and colleagues in the June issue of...

Field of Interest: Gastroentero...

Type: News Item

« first
‹ previous
…
70
71
72
73
74
75
76
77
78
…
next ›
last »

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters